You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CANCER,NOS Trial in Worldwide (Lirilumab, Nivolumab, Ipilimumab)

Completed
  • CANCER,NOS
  • San Francisco, California
  • +29 more
Dec 10, 2020

Breast Cancer, Tumor Metastasis Trial in San Sebastián de los Reyes, Valencia (Vinorelbine, Gemcitabine)

Completed
  • Breast Cancer
  • Neoplasm Metastasis
  • San Sebastián de los Reyes, Madrid, Spain
  • +1 more
Feb 19, 2019

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

Prostate Cancer Trial in Houston (imatinib mesylate, docetaxel)

Completed
  • Prostate Cancer
  • Houston, Texas
    U.T. M.D. Anderson Cancer Center
Oct 30, 2018

Hepatocellular Carcinoma Trial in Taichung (Xiang Sha Liu Jun Zi Decoction dry powder, XSLJZ Placebo)

Enrolling by invitation
  • Hepatocellular Carcinoma
  • Xiang Sha Liu Jun Zi Decoction dry powder
  • XSLJZ Placebo
  • Taichung, 西屯區, Taiwan
    China Medical University hospital
Dec 9, 2021

Urothelial Carcinoma, Bladder Cancer Trial in Zhengzhou (Toripalimab, Gemcitabine)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Nov 24, 2021

Drug Resistance in Immune Checkpoint Inhibitors of Non-small

Recruiting
  • Non-Small Cell Lung Cancer
  • Anti-PD-1/PD-L1 monoclonal antibody
  • Shanghai, Shanghai, China
    Xiaomin Niu
Jul 24, 2021

Prostate Adenocarcinoma Trial in Salt Lake City (MVA-BN-Brachyury)

Withdrawn
  • Prostate Adenocarcinoma
  • MVA-BN-Brachyury
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Sep 21, 2021

Choice in Prostate Cancer Patients

Recruiting
  • Prostate Cancer
  • No intervention
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Jan 20, 2022

Breast Tumors, Radiotherapy, Lymphedema Trial in Canada (Locoregional radiation treatment - Conventional fractionation,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Locoregional radiation treatment - Conventional fractionation
  • Locoregional radiation treatment - Hypofractionation
  • Calgary, Alberta, Canada
  • +12 more
May 26, 2022

Advanced Soft Tissue Sarcoma, Advanced Epithelioid Sarcoma Trial in Worldwide (Tazemetostat, Placebo, Doxorubicin HCl)

Recruiting
  • Advanced Soft Tissue Sarcoma
  • Advanced Epithelioid Sarcoma
  • Duarte, California
  • +20 more
Jan 31, 2022

Melanoma Trial in Worldwide (Durvalumab, Dabrafenib, Trametinib)

Completed
  • Melanoma
  • Durvalumab
  • +2 more
  • Scottsdale, Arizona
  • +10 more
May 15, 2019

Lung Metastatic Advanced Gastric Cancer and NSCLC Treated With

Completed
  • Gastric Cancer Metastatic to Lung
  • Lung Cancer
  • lung cavitation
  • (no location specified)
Aug 14, 2018

Microbiome in Immunotherapy naïve NSCLC Patients Receiving

Recruiting
  • NSCLC Stage IV
  • NSCLC, Recurrent
  • Microbiome
  • Fairway, Kansas
  • +2 more
Sep 28, 2021

Prostate Cancer Trial in Houston (Estramustine, Thalidomide, Paclitaxel (Taxol))

Completed
  • Prostate Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 30, 2018

Immune Infiltration in High-risk Non Muscle Invasive Bladder

Completed
  • Bladder Cancer
  • Samples of bladder tissue
  • Talence, France
    Centre Hospitalier Universitaire de Bordeaux
Jan 25, 2021

Colorectal Cancer Trial in Seoul (Regorafenib)

Unknown status
  • Colorectal Cancer
  • Seoul, Songpa, Korea, Republic of
    Asan Medical Center
Jan 27, 2019

Epilepsy Trial in Worldwide (Brivaracetam)

Completed
Has Results
  • Epilepsy
  • Phoenix, Arizona
  • +99 more
Aug 16, 2021

HER2-expressing Cancers Trial in United States (Zanidatamab, Evorpacept)

Recruiting
  • HER2-expressing Cancers
  • Birmingham, Alabama
  • +11 more
Apr 8, 2022

Unresectable Pancreatic Cancer Trial (creon 35.000 Ph.U (R), Best Standarard of Care)

Not yet recruiting
  • Unresectable Pancreatic Cancer
  • creon 35.000 Ph.U (R)
  • Best Standarard of Care
  • (no location specified)
Oct 19, 2023

Prostate Cancer Trial in Hamilton, London, Toronto (18F-DCFPyL PET/CT scan)

Completed
  • Prostate Cancer
  • 18F-DCFPyL PET/CT scan
  • Hamilton, Ontario, Canada
  • +3 more
Mar 24, 2022

Advanced Solid Tumor Trial in Australia, United States (Mirdametinib, BGB-3245)

Recruiting
  • Advanced Solid Tumor
  • La Jolla, California
  • +5 more
Jan 26, 2023

Malignant Melanoma Trial in France, Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Terminated
  • Malignant Melanoma
  • Marseille, France
  • +6 more
Jan 29, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (GP combine with Tislelizumab neoadjuvant therapy+CCRT)

Recruiting
  • Nasopharyngeal Carcinoma
  • GP combine with Tislelizumab neoadjuvant therapy+CCRT
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 15, 2021

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Beverly Hills, Los Angeles

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Beverly Hills, California
  • +1 more
Jun 16, 2022